Monika Z.
- Country
- Czechia
- Department
- Neurologická ambulance
Research Overview
- Long-Term Safety and Tolerability of Atogepant for Migraine Prevention in Chronic or Episodic Migraine: A Phase 3, 156-Week Extension Study
- Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of Lu AG09222 for Migraine Prevention in Adults with Episodic and Chronic Migraine
- Efficacy and Safety Evaluation of Clostridium Botulinum Neurotoxin Type A in Chronic Migraine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 59 of 152 partner sites.
Specializations
Headache Medicine
The investigator specializes in migraine disorders, with particular emphasis on preventative treatment approaches for patients who have not responded to conventional therapies.
- Chronic Migraine Management
- Episodic Migraine Treatment
- Preventative Therapy Development
Areas of focus include both migraine with aura and migraine without aura, exploring innovative therapeutic solutions for long-term migraine prevention.
Treatment-Resistant Conditions
The investigator focuses on developing therapeutic solutions for treatment-refractory migraine cases, particularly in adult populations who have not achieved success with existing preventative treatments.
- Novel Therapeutic Approaches
- Long-term Prevention Strategies
- Treatment-resistant Cases
Research interests encompass the evaluation of new therapeutic agents for enhanced migraine prevention in challenging cases.
Clinical Neurology
The investigator's work centers on neurological disorders with a specific focus on headache medicine and innovative preventative treatments.
- Preventative Medicine
- Neurological Therapeutics
- Long-term Treatment Outcomes
Expertise extends to the development and evaluation of extended-duration therapeutic interventions for neurological conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.